That is good intel to know.Any opinions on UPS being able to maintain its current dividend? On the recent pull back it’s now got a yield of 7.3%. I know their union expenses can be tough, but I don’t see the shipping business slowing down anytime soon?
They have been a poorly run company almost forever. Look at their stock price for 1, 5, 10 ------years.Any opinions on UPS being able to maintain its current dividend? On the recent pull back it’s now got a yield of 7.3%. I know their union expenses can be tough, but I don’t see the shipping business slowing down anytime soon?
Any opinions on UPS being able to maintain its current dividend? On the recent pull back it’s now got a yield of 7.3%. I know their union expenses can be tough, but I don’t see the shipping business slowing down anytime soon?
losing the battle in the weigh loss market and the fallout with HIMS. Lilly was able to capture Zepbound as the only glp1 approved for OSA.Gosh, I haven't really paid attention to NVO since I cashed a year or so ago for a handsome profit. What happened to them? LLY is still cooking and I'm ready for AMGN to pop.
Both clipped $185 overnight. I got in at $60 on AMD and sold at $90, not happy about that one today.I think I'm going to redirect my weekly contributions to NVDA and start gearing toward AMD. The bull run I thought was going to happen seems to have started early amid tech earnings.
There are arguments to be made that AMD's ceiling is higher, and I say that as Jensen's fanboy. The market cap difference is stunning.
Plus, as a tech dude, I can tell you the gap is closing between the two. This time next year AMD might be NVDA's GPU equal.
Plus, CPUs.
Curious how long HIMS can keep working their magic. Any idea? I know many in the mostly female friends who have tried the compounded Ozempic.losing the battle in the weigh loss market and the fallout with HIMS. Lilly was able to capture Zepbound as the only glp1 approved for OSA.
10-12 years ago, NVO with Victoza was on top of the diabetes market with little to no competition for the injectables. Flooded the market with samples, reps and advertising.
Believe HIMS has room to grow and compete with pharmaceutical companies and telehealth. Multiple products at a lower cost, almost like TEVA pharma when they controlled the generic market.Curious how long HIMS can keep working their magic. Any idea? I know many in the mostly female friends who have tried the compounded Ozempic.
Seems to work for weight loss, but some can't tolerate the side effects.
HIMS....was allowed to use the NVO secret sauce to "compound" making the weight loss drug affordable.
They were allowed to do that because the juice was in shortage.
Now, the shortage is over. The courts ruled that that they need to stop compounding. However, per NVO, they aren't complying with the court order.
In the long haul, HIMS will perhaps own NVO a lot of money. In the short haul, we down 22% today.
Accountants don't retire. They just lose their balance.I think that the labor contract is priced in to the share price. They’re down about 60% since 4 years ago. They’ve also locked down driver pay for several years now. But the unions are pissed that UPS has indicated that they will close some of their distribution centers to save costs (that’s the kind of thing that happens when unions drive up labor costs). They’d be fools though to go on strike with such a generous pay package deal recently negotiated.
Their other major costs include fuel, which is cheap ATM. But the unions are making them have A/C in their new trucks which will reduce the mpg. Kind of a big deal when they have thousands of delivery vans rolling. Insurance is another huge cost that has gone up a bunch.
The dividend should be safe for a year or 2. The earnings per share is $6.72 and the dividends being paid are $1.64/quarter ($6.56). So they can pay it without having to issue debt or sell shares to raise cash for now. The P/E ratio is 13.5x and the forward P/E ratio is estimated at 13.1x. So earnings are expected to be flat to slightly up which is much better than getting slammed. Actual earnings (not GAAP earnings) might actually be better than indicated since they’ll be writing off their fleet purchases immediately rather than sticking the costs on their balance sheet and spreading the expense over several years.
Their Amazon business is shrinking, but that’s common knowledge at this point.
Their biggest threat might be from the Uber/Lyft/DoorDash drivers that are handling smaller packages. I bought a lawn mower last summer and was surprised that it was delivered by some guy in his personal vehicle.
Edit: I don’t keep up with current accounting practices. Perhaps companies will continue to recapture fixed asset costs using depreciation and only writing off those asset purchases for tax purposes. In which case the net effect could be inflating reported earnings since the tax benefit increases the bottom line. Unless they also spread the tax savings over time in some type of deferred tax liability benefit account. Accounting is boring.
Is it safe to assume there is intense competition for the compounded Ozempic?Yes, NVO didn't pay enough attention to manufacturing /demand. LLY anticipated demand much better. Also due to their own incompetence, NVO allowed generic Ozempic to be approved in Canada and it will be available commercially next year, I believe. Keep an eye on that development. A generic Ozempic in Canada might also make its way into the US.
I got in AMD at $102 and still running although I thought about ditching it until the recent rebound.Both clipped $185 overnight. I got in at $60 on AMD and sold at $90, not happy about that one today.
I am sure HIMS buys Ozempic from several compounding pharmacies but I don't know how competitive they are in regards to price. It's a totally different business than generic drugs so my GUESS is that compounding pharmacies don't have experience in high volume/low price drug manufacturing.Is it safe to assume there is intense competition for the compounded Ozempic?
I'm only familiar with HIMS because that the one NVO is complaining about.
The weight loss stuff is changing so fast, I'm unsure how to keep up and/or try to make a buck. Novo Nordisk just tumbled like a rock, and they are a huge company.I am sure HIMS buys Ozempic from several compounding pharmacies but I don't know how competitive they are in regards to price. It's a totally different business than generic drugs so my GUESS is that compounding pharmacies don't have experience in high volume/low price drug manufacturing.
The first generic Ozempic in Canada will be manufactured by Sandoz and they are a huge generic drug company.
Fully into HIMS at an average of 63.23.After a weekend of DD, I'm changing direction and going to do something dumb. However, not wagering much. As mentioned earlier about Telsa, this is truly more gambling than investing.
At close today, PLTR reports earnings. For all their quirkiest and naughty boy behavior, I love the brains of Peter Thiel and Alex Karp. Within a year of their IPO, I owned shares cheap. Don't recall exact price/timeline but under $20. It was just so volatile, the violent dips caused stress, and I bailed out. Bad move! The aftermarket action today will be exciting.
Under the radar, HIMS is reporting at the same time. That company was funded partially by Peter Thiel. As I understand, the CEO, Andrew Dudum, trained in a Thiel school/company early career.
In a pure move of "betting on the jockey", if I can get in for $63-64 sometime....I'm gambling a little newfound cash. The money is in Vanguard and they do not offer premarket trades. More subdued than PLTR, the afterhours action on HIMS should also be wild. No true clue on which direction.
Purely based on 'from the gut', I think both companies open higher tomorrow and will be somewhat higher by end of month. Again, HIMS is so volatile, unsure if I can stomach a long ride. Time will tell.
For me, a high-risk play. Buffett would not approve. Fingers crossed...